Amgen, Inc. (AMGN)
388.16
+8.83
(+2.33%)
USD |
NASDAQ |
Feb 27, 16:00
387.97
-0.19
(-0.05%)
After-Hours: 20:00
Amgen Research and Development Expense (TTM) : 7.281B for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Gilead Sciences, Inc. | 5.688B |
| Johnson & Johnson | 14.72B |
| Eli Lilly & Co. | 13.34B |
| Merck & Co., Inc. | 12.71B |
| Regeneron Pharmaceuticals, Inc. | 5.306B |